Open-label Drug Interaction Study Between Eslicarbazepine Acetate and Phenytoin.
NCT02283827 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 32
Last updated 2014-12-18
Summary
Single centre, open-label, multiple doses, two parallel study groups each receiving two formulations in a one-sequence design
Conditions
Interventions
- DRUG
-
BIA 2-093
- DRUG
-
Phenytoin
Sponsors & Collaborators
-
Bial - Portela C S.A.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2007-01-31
- Primary Completion
- 2007-03-31
- Completion
- 2007-03-31
More Related Trials
-
A Clinical Study of Belzutifan (MK-6482) Alone or With Phenytoin in Healthy Participants (CA46602/MK-6482-035)
NCT06903715 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Potential Pharmacokinetic Interactions Between Phenytoin or Carbamazepine and Telaprevir
NCT01635829 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Eslicarbazepine Acetate on the Pharmacokinetics of Gliclazide in Healthy Volunteers
NCT02777671 ·Status: COMPLETED ·Phase: PHASE1
-
Tolerability and Pharmacokinetics of a Single 900 mg Oral Dose of BIA 2-093 and Oxcarbazepine in Healthy Volunteers
NCT01678976 ·Status: COMPLETED ·Phase: PHASE1
-
The Effect of BIA 2-093 on the Steady-state Pharmacodynamic and Pharmacokinetic Profiles of Warfarin
NCT02287415 ·Status: COMPLETED ·Phase: PHASE1
-
A Sequential Multiple Ascending Dose Study of the Safety and Pharmacokinetics of Eslicarbazepine Acetate in Adult Healthy Volunteers
NCT01879332 ·Status: COMPLETED ·Phase: PHASE1
-
A Single Centre, Phase I, Double-blind, Randomised, Placebo-controlled Study to Investigate the Safety, Tolerability, Pharmacokinetic Profile and Effects on EEG of Single Rising Oral Doses of BIA 2-093
NCT02171195 ·Status: COMPLETED ·Phase: PHASE1
-
An Open-label, Multiple-dose, Single-centre Study, Investigating the Pharmacokinetics of BIA 2-093
NCT02281526 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Effect of UGT Inhibition by Valproic Acid on the Pharmacokinetics of BIIB074
NCT03385525 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures
NCT00988429 ·Status: COMPLETED ·Phase: PHASE3
-
Trial to Evaluate the Effect of Eslicarbazepine Acetate on Cardiac Repolarization
NCT02283788 ·Status: COMPLETED ·Phase: PHASE1
-
The Tolerability and Effect of Food on the Pharmacokinetics of a Single 800 mg Oral Dose of BIA 2-093
NCT02170649 ·Status: COMPLETED ·Phase: PHASE1
-
A Double-blind, Randomised, Placebo-controlled, Rising Multiple Dose Study to Investigate the Safety, Tolerability, Steady State Pharmacokinetic Profile and CNS Effects of BIA 2-093
NCT02171234 ·Status: COMPLETED ·Phase: PHASE1
-
Food Effect and Dosage Form Proportionality Study of Eslicarbazepine Acetate
NCT02288312 ·Status: COMPLETED ·Phase: PHASE1
-
Eslicarbazepine Acetate (BIA 2-093) as Monotherapy in Patients With Newly Diagnosed Partial-onset Seizures
NCT02484001 ·Status: COMPLETED ·Phase: PHASE3
-
Steady-state Pharmacokinetics of BIA 2-093 and Oxcarbazepine in Healthy Volunteers
NCT01679002 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Repeat Administration of Eslicarbazepine Acetate on the Pharmacokinetics of a Combined Oral Contraceptive
NCT00898560 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Pharmacokinetic Study of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
NCT02535091 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
NCT00866775 ·Status: COMPLETED ·Phase: PHASE3
-
Single-dose Pharmacokinetics and Relative Bioavailability of an Oral Suspension and Two Tablet Formulations of BIA 2-093
NCT02279667 ·Status: COMPLETED ·Phase: PHASE1
-
A Placebo-controlled Study to Investigate Safety and Efficacy of BIA 2-093
NCT02170077 ·Status: COMPLETED ·Phase: PHASE2
-
Disposition of Eslicarbazepine Acetate and Its Metabolites S-licarbazepine and R-licarbazepine
NCT02281591 ·Status: COMPLETED ·Phase: PHASE1
-
A Comparison of the Effectiveness and Safety of Topiramate and Phenytoin in Patients With New Onset Epilepsy Requiring Rapid Initiation of Antiepileptic Drug Treatment
NCT00210782 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Eslicarbazepine Acetate as Monotherapy for Patients With Newly Diagnosed Partial-onset Seizures
NCT01162460 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of a Drug to be Used in Addition With Another Drug to Treat Adults With Uncontrolled Partial-onset Seizures
NCT03116828 ·Status: COMPLETED ·Phase: PHASE4